immune system
N |
• mice exhibit normal numbers and functions of lymphocytes other than NK cells
• despite the reduction in NK cells and function, mice exhibit a normal generalized Shwartzman reaction and normal antibody response to TI type 2 antigen exposure
|
• mice exhibit a reduction in the number of NK1.1+ CD3- spleen cells compared to in wild-type mice
• NK1.1+ CD3- cells are virtually absent from the peripheral blood
|
• slight decrease in the spleen
|
• unlike in wild-type mice, splenocytes lack natural killing activity towards YAC-1
• mice fail to clear injected tumor cells as do wild-type mice
|
• following injection with LPS, serum levels of IFN-gamma are lower than in similarly treated wild-type mice
• however, mice produce normal levels of IFN-gamma in response to exposure to IL-12
|
neoplasm
• when injected with B16 tumor cells, mice exhibit a greater than 60-fold higher number of lung metastases compared to in similarly treated wild-type mice
• however, the number of liver metastases is normal following injection with B16 tumor cells
|
cardiovascular system
• mice exhibit impaired arteriogenesis following occlusion compared to in similarly treated wild-type mice
|
homeostasis/metabolism
• following injection with LPS, serum levels of IFN-gamma are lower than in similarly treated wild-type mice
• however, mice produce normal levels of IFN-gamma in response to exposure to IL-12
|
hematopoietic system
• mice exhibit a reduction in the number of NK1.1+ CD3- spleen cells compared to in wild-type mice
• NK1.1+ CD3- cells are virtually absent from the peripheral blood
|
• slight decrease in the spleen
|
• unlike in wild-type mice, splenocytes lack natural killing activity towards YAC-1
• mice fail to clear injected tumor cells as do wild-type mice
|